| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/18/2010 | WO2004099390A3 Molecules for disease detection and treatment |
| 02/18/2010 | US20100041871 Preparation of Canola Protein Isolate from Canola Oil Seeds ("Blendertein") |
| 02/18/2010 | US20100041869 Ionic liquid supported synthesis |
| 02/18/2010 | US20100041611 Rapid Isolation of Osteoinductive Protein Mixtures From Mammalian Bone Tissue |
| 02/18/2010 | US20100041162 Use of arylboronic acids in protein labelling |
| 02/18/2010 | US20100041144 Mammalian Cytokine; Related Reagents |
| 02/18/2010 | US20100040763 Preparation of Canola Protein Isolate Without Heat Treatment ("C200Ca") |
| 02/18/2010 | US20100040665 Method for obtaining three-dimensional structures for tissue engineering |
| 02/18/2010 | US20100038297 Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof |
| 02/18/2010 | CA2733782A1 Methods for purifying antibodies using protein a affinity chromatography |
| 02/18/2010 | CA2732882A1 Production, formulation, and uses of stable liquid harpin protein formulations |
| 02/18/2010 | CA2731943A1 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2154147A1 A truncated l1 protein of human papillomavirus 16 |
| 02/17/2010 | EP2153877A1 Mixed graft polymers for ion exchange chromatography |
| 02/17/2010 | EP2152810A1 A cyanine-based probe\tag-peptide pair for fluorescence protein imaging and fluorescence protein imaging methods |
| 02/17/2010 | EP1633774B1 Macrocyclic antagonists of the motilin receptor |
| 02/17/2010 | EP1597269B1 A method of generating metal chelating affinity ligands |
| 02/17/2010 | CN101648989A Long-acting type collagen and method for preparing same |
| 02/16/2010 | US7662936 Mass spectrometry of antibody conjugates |
| 02/16/2010 | US7662934 Process for reducing biomass-biomass or biomass—resin interactions |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662930 Polishing steps used in multi-step protein purification processes |
| 02/16/2010 | US7662926 Selectively bind human FcyRIIB, with little or no binding to other human Fc gamma Rs, e.g., human Fc gamma RIIA; atherosclerosis; leukocyte adhesion deficiency; rheumatoid arthritis; systemic lupus erythematosus (SLE); diabetes mellitus; multiple sclerosis; Reynaud's syndrome; autoimmune thyroiditis; |
| 02/16/2010 | US7662925 Optimized Fc variants and methods for their generation |
| 02/16/2010 | US7662922 Canola protein isolate compositions |
| 02/16/2010 | US7662918 SBD from glucoamylase of fungi genus Rhizopus for use as a tag; a recombinant protein containing this sequence can be more easily purified and separated by contacting with an affinity matrix such as starch, to which it will bind |
| 02/16/2010 | US7662915 specifically conjugating polyethylene glycol to targeted sites of the synthetic peptides; pegylation; synthetic peptides having selectively protected amines of untargeted sites |
| 02/16/2010 | US7662914 Native chemical ligation with three or more components |
| 02/16/2010 | US7662777 Particularly oral mucositis as a result of chemotherapy or radiotherapy |
| 02/16/2010 | US7662775 Method for screening agents for the treatment of diabetes |
| 02/16/2010 | US7662644 Use of specified fluorescent dyes to conjugate to antibody; detecting binding of an antibody to an antigen; antibody conjugate |
| 02/16/2010 | US7662623 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/16/2010 | US7662602 polypeptide which is encoded by a polynucleotide comprising a nuclotide sequence which hybridizes under at least high stringency conditions with the mature specific polypeptide coding sequence or its full-length complementary strand; detergent |
| 02/16/2010 | US7662592 in vitro biosynthesis; Lactobacillus, Streptococcus, Enterococcus strains |
| 02/16/2010 | US7662399 BASB054 polypeptides |
| 02/16/2010 | CA2402748C Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
| 02/16/2010 | CA2224444C Type f botulinum toxin and use thereof |
| 02/16/2010 | CA2154231C Process for the preparation of a c1-esterase inhibitor concentrate (c1-inh) and concentrate thus obtained, for therapeutic uses |
| 02/11/2010 | WO2010017292A1 Synthesis of glatiramer acetate |
| 02/11/2010 | WO2010016551A1 Processes for removing dibenzofulvene |
| 02/11/2010 | WO2010016069A1 A process for preparation of insulin compounds |
| 02/11/2010 | WO2010016067A2 Affinity purification by cohesin-dockerin interaction |
| 02/11/2010 | WO2010015864A1 Solvent resistant diafiltration of peptides, pna or oligonucleotides |
| 02/11/2010 | US20100036103 Method for producing apoprotein |
| 02/11/2010 | US20100036099 Soluble canola protein isolate production ("nutratein") |
| 02/11/2010 | US20100036093 Cholesterolamine-introduced poly-gamma-glutamic acid derivative |
| 02/11/2010 | US20100036092 Synthesis of Glatiramer Acetate |
| 02/11/2010 | US20100036090 Glycoalkaloid removal |
| 02/11/2010 | US20100035814 N-Terminal Pegylated Prolactin Receptor Molecules |
| 02/11/2010 | US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034758 Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals |
| 02/11/2010 | US20100034740 Radiofluorination methods |
| 02/11/2010 | US20100032293 Droplet Dispensing Device and Methods |
| 02/11/2010 | CA2733500A1 Synthesis of glatiramer acetate |
| 02/11/2010 | CA2733409A1 Solvent resistant diafiltration of peptides, pna or oligonucleotides |
| 02/11/2010 | CA2733117A1 Template-fixed peptidomimetics |
| 02/10/2010 | EP2151450A1 Method for processing microbiologically produced cyclic oligopeptides |
| 02/10/2010 | EP1532261B1 Methods and dna constructs for high yield production of polypeptides |
| 02/10/2010 | CN100588661C Process for preparing recombined placental growth factor |
| 02/09/2010 | US7660677 Method of designing physiologically active peptide and use thereof |
| 02/09/2010 | US7659380 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659369 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides |
| 02/09/2010 | US7659249 Membrane-permeable NFAT inhibitory peptide |
| 02/09/2010 | US7659082 Utilizing SCN9A (sodium channel alpha subunits) gene and expression products thereof for the screening and identification of therapeutic agents; in vitro method for identifying a selective inhibitor of human SCN9A |
| 02/09/2010 | US7659076 Binding of pathological forms of prion proteins |
| 02/09/2010 | US7658917 A beta aggregation core domain and a modifying group coupled thereto such that the compound alters the aggregation or inhibits the neurotoxicity of natural beta amyloid peptides when contacted with the peptides. |
| 02/09/2010 | US7658830 Capillary array and electrophoresis apparatus, and methods |
| 02/09/2010 | CA2451962C Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2370694C Extraction of integral membrane proteins |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/09/2010 | CA2293806C Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 02/04/2010 | WO2010012786A1 Method for processing microbiologically produced cyclic oligopeptides |
| 02/04/2010 | WO2010012358A1 Graft copolymers for ion exchange chromatography |
| 02/04/2010 | WO2010012073A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 02/04/2010 | WO2009152176A3 Recovery of insoluble enzyme from fermentation broth and formulation of insoluble enzyme |
| 02/04/2010 | WO2009090227A3 PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN α1 LOOP 2 OR β2 LOOP 1 OF AN ADRENORECEPTOR |
| 02/04/2010 | US20100029917 Use of ionic liquids for membrane protein extraction |
| 02/04/2010 | US20100029916 Process for production of bivalirudin |
| 02/04/2010 | US20100029915 Method and system for selective isolation of target biological molecules in a general purpose system |
| 02/04/2010 | US20100029914 Novel packing material with excellent hydrophilicity and process for producing the same |
| 02/04/2010 | US20100029905 method for purifying protein |
| 02/04/2010 | US20100029904 Carrier for Separation, Method for Separation of Compound, and Method for Synthesis of Peptide Using the Carrier |
| 02/04/2010 | US20100029885 Crosslinked polymer sheets and methods for making such |
| 02/04/2010 | US20100029546 preparation method of galactosyl-has magnetic nanoparticles containing adriamycin |
| 02/04/2010 | US20100028967 Method of changing property or function of substance and method of eliminating biofunction of cell |
| 02/04/2010 | US20100028952 Fermentation and purification of actinomadura chromoprotein and related species |
| 02/04/2010 | US20100028926 Novel enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028525 Low Fat, Clear, Bland Flavored Whey Products |
| 02/04/2010 | US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 02/04/2010 | DE19681438B4 Verwendung von Polypeptidanaloga mit erhöhter Elektrotransportierbarkeit und Parathormon (PTH) - Analog Use of polypeptide analogs with increased Elektrotransportierbarkeit and parathyroid hormone (PTH) - Analog |
| 02/04/2010 | CA2732398A1 Graft copolymers for ion exchange chromatography |
| 02/04/2010 | CA2732146A1 Nonimmunosuppressive cyclosporine analogue molecules |